top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Cellular and Molecular Mechanisms of Nephropathic Cystinosis
Cellular and Molecular Mechanisms of Nephropathic Cystinosis
Autore Levtchenko Elena N
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (230 p.)
Soggetto topico Medicine and Nursing
Pharmacology
Soggetto non controllato 3-dimensional models
apoptosis
arterial spin labelling
autophagy
azoospermia
biomarkers
bone
bone-muscle wasting
CD34+ hematopoietic stem and progenitor cells
cell and animal models
cell model
central nervous system
chitotriosidase
clinical course
clinical trial
cortical atrophy
CTNS-pathogenic variants
cysteamine
cystine
cystine blood level
cystinosis
disulfiram
endocytosis
endolysosome
epithelial cell differentiation
fertility
fibroblast growth factor 23
fractures
galectin-3
gene therapy
genotype
histopathology
history
hollow fiber membrane
homeostasis
hypogonadism
infantile nephropathic cystinosis
inflammasome
interleukins
investigational new drug application
kidney
kidney progenitors
kidney proximal tubule
leptin
lysosomal storage disease
lysosomal storage diseases
lysosomal storage disorder
macrophages
mice
mitochondrial distress
mouse model
nephropathic cystinosis
newborn screening
newborn screening for cystinosis
novel therapies
osteoclast
osteoclasts
pre-clinical studies
programmed cell death
proximal tubular cells
sclerostin
therapeutic monitoring
treatment strategies for cystinosis
zebrafish
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910585941103321
Levtchenko Elena N  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Diet Therapy and Nutritional Management of Phenylketonuria
Diet Therapy and Nutritional Management of Phenylketonuria
Autore MacDonald Anita
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (376 p.)
Soggetto topico Research & information: general
Biology, life sciences
Food & society
Soggetto non controllato phenylketonuria
special low protein foods
nutritional composition
UK
macronutrients
phenylketonuria (PKU)
consensus
Delphi method
food labelling
phenylalanine
Phe
protein
exchanges
PKU
glycomacropeptide
amino acid
absorption
diet therapy
protein substitute
gastrointestinal symptoms
prolonged release
satiety
macronutrient intake
protein content
free from
gluten free
aspartame
sugar tax
phenylalanine hydroxylase deficiency
hyperphenylalaninemia
medical formula
amino acid mixture
tetrahydrobiopterin
sapropterin
BH4
body composition
bone mineral density
bone turnover markers
osteoporosis
blood biochemistry
casein glycomacropeptide
amino acid protein substitute
low-protein diet
newborn screening
metabolic control
guidelines
nitrogen balance
amino acid catabolism
blood urea nitrogen
body mass index
obesity
overweight
phenylalanine restriction
phenylalanine-restricted diet
food
school
IHCP
parent/caregiver experiences
England
prescribing patterns
costs
adult phenylketonuria
standard operating procedure
inherited metabolic disorders
dietary management
eating out
low protein food
restaurants
amino acids
adherence
epigenetics
health
preconception
women
dietary patterns
food frequency questionnaire
validation
reproducibility
ISBN 3-0365-5320-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910619462903321
MacDonald Anita  
MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches
Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches
Autore Moro Enrico
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (301 p.)
Soggetto topico Medicine
Soggetto non controllato A4GALT
alpha-galactosidase A
animal models
astrogliosis
autophagy
axon guidance
biomarkers
bone involvement
cathepsin D
chloroquine
clathrin
Dkk1
dried blood spot
endocytic pathways
endocytosis
enzyme replacement therapy
exosomes
experimental therapies
Fabry disease
GAA biomarker
Gaucher disease
Gaucher Disease
gene therapy
GLA gene
globotriaosyl-sphingosine (lysoGb3)
globotriaosylceramide (Gb3)
globotriaosylsphingosine
glycogen
hematopoietic stem cell transplantations
Hurler syndrome
IGF2R/M6P
iPSC
Krabbe disease
lyso-Gb3
lysosomal diseases
lysosomal storage disorder
lysosomal storage disorders
lysosomal targeting
lysosomal α-glucosidase
lysosome
lysosomes
MIP-1β
mucolipidosis II
mucopolysaccharidosis IIIB
mucopolysaccharidosis type I
muscle
NAGLU
neurodegenerative disease
neuronal circuit
neuronopathy
newborn screening
Osteoimmunology
Osteopontin
Parkinson disease
pharmacological chaperone therapy
pharmacological chaperones
Pompe disease
precision medicine
psychosine
quantitative proteomics
RANK/RANKL
rhGAA
satellite cells
second tier test
sortilin
substrate reduction therapy
tandem mass spectrometry
TGF-beta
Twitcher mouse
variant interpretation
viral vectors
visual cortex
visual system
Wnt/β-catenin
Wnt3a
α-galactosidase A
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Lysosomal Storage Disorders
Record Nr. UNINA-9910557545503321
Moro Enrico  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Molecular Basis and Gene Therapies of Cystic Fibrosis
Molecular Basis and Gene Therapies of Cystic Fibrosis
Autore Engelhardt John
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (210 p.)
Soggetto topico Medicine
Soggetto non controllato airway basal cell
baculovirus
biomarker
CFTR
CFTR gene
CFTR modulators
CFTR variants
CFTR-related disorders
common and new pathogenic variants
cyclophosphamide
cystic fibrosis
Cystic fibrosis
disease liability
drug development
enterotoxin gene cluster
ethnic Russian population
exosomes
functional assay
gene therapy
genotype-guided therapy
genotype-phenotype correlations
gut-lung axis
health policies
health policy
human nasal epithelial cells
incidence
insect cells
interpretation
lentivirus
lung
lung microbiome
metagenomics
microvesicles
miRNA
molecular diagnosis
MRSA
newborn screening
next generation sequencing
Next Generation Sequencing (NGS)
organoids
penetrance
pre-clinical in vitro models
primary cells
proteostasis
rAAV2/HBoV1
small molecules
Staphylococcus aureus
superantigen
survival
transcriptomics
transient immunosuppression
trypsinogen
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557392203321
Engelhardt John  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Neonatal Screening for Critical Congenital Heart Defects / Andrew Ewer
Neonatal Screening for Critical Congenital Heart Defects / Andrew Ewer
Autore Ewer Andrew
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (98 p.)
Soggetto non controllato altitude
CCHD screening in the US
screening
coarctation of aorta
oxygen saturation
neonates
critical congenital heart disease screening
newborn screening pulse oximetry
home births
health policy
congenital heart disease
neonatal screening
pulse oximetry
cost-effectiveness
hypoxia
neonate
newborn
critical congenital heart disease
state screening
pulse oximetry screening
economic evaluation
screening algorithm
newborn screening
Germany
congenital heart defects
ISBN 9783039210497
3039210491
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910346681703321
Ewer Andrew  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Newborn Screening for Cystic Fibrosis
Newborn Screening for Cystic Fibrosis
Autore Barben Jürg
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (126 p.)
Soggetto topico Medicine
Soggetto non controllato biochemical screening
bioethics
CF screen positive
CF transmembrane conductance regulator-related metabolic syndrome
CFSPID
cost
cystic fibrosis
cystic fibrosis screen positive
diagnosis
DNA
DNA analysis
dried blood spot
extended genetic analysis
health policy
immunoreactive trypsin
immunoreactive trypsin(ogen)
immunoreactive trypsinogen
incidence
inconclusive diagnosis
inconclusive diagnosis (CFSPID)
malnutrition
meconium ileus
missed case
n/a
newborn bloodspot screening
newborn screen
newborn screening
next generation sequencing
pancreatitis associated protein
parental information
presumptive diagnosis
prognosis
psychological impact
radioimmunoassay
sensitivity
sweat test
target disorder
therapy
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557291703321
Barben Jürg  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Newborn Screening for Pompe Disease
Newborn Screening for Pompe Disease
Autore Hwu Wuh-Liang
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (146 p.)
Soggetto topico Technology: general issues
Soggetto non controllato acid α-glucosidase
alpha glucosidase
c.-32-13T&
California
cross-reactive immunologic material
diagnosis
dried blood spots
enzyme replacement therapy
follow-up
G
GAA sequencing
genotype-phenotype correlation
gt
immune modulation therapy
infantile onset Pompe disease
infantile-onset
infantile-onset Pompe disease
late onset Pompe disease
late-onset
lysosomal storage diseases
n/a
new disorders implementation
newborn screening
next generation sequencing
patient perspective
Pompe disease
Pompe disease diagnostics testing
presymptomatic
pseudodeficiency
treatment and follow-up
variant cut-off
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557494603321
Hwu Wuh-Liang  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Newborn Screening for Sickle Cell Disease and other Haemoglobinopathies / Elena Cela, Jacques Elion, Stephan Lobitz, Raffaella Colombatti
Newborn Screening for Sickle Cell Disease and other Haemoglobinopathies / Elena Cela, Jacques Elion, Stephan Lobitz, Raffaella Colombatti
Autore Cela Elena
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (162 p.)
Soggetto topico Chemistry
Soggetto non controllato glucose-6-phosphate dehydrogenase
hydroxyurea/hydroxycarbamide
cord blood
screening
hemoglobin pattern
capillary electrophoresis
sickle cell disease
(recommended) screening panel
vaso-occlusive crisis
Guthrie spots
newborn screening)
foetal haemoglobin
harmonisation
review
birth prevalence
G6PD deficiency
prevention
end-organ damage
thalassemia
MALDI-TOF
IEF
acute chest syndrome
India
sickle cell and thalassaemia screening programme
'Getting to Outcomes'
newborn screening
hemoglobinopathy
service users
public health engagement
automated HPLC
Kaduna State
gene therapy for haemoglobinopathies
?-globin gene
methods
neonatal screening program
malaria
Plasmodium vivax
sub-Saharan Africa
patient organisations
health policy
pathophysiology
Sickle Cell Disease
mass spectrometry
sickle cell disorder
neonatal screening
non-tribal
Nigeria
point-of-care
HPLC
laboratory methods
registry
patient advocacy
bone marrow transplant
anaemia
hemoglobinopathies
tribal
newborn
burden of disease
patient representatives
diagnostics
policy making
haemolysis
Caribbean
high performance liquid chromatography (HPLC)
sickle cell disease (SCD)
implementation science
ISBN 9783039216154
3039216155
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910367754603321
Cela Elena  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Towards Mechanism-based Treatments for Fragile X Syndrome / Inbal Gazy, Daman Kumari
Towards Mechanism-based Treatments for Fragile X Syndrome / Inbal Gazy, Daman Kumari
Autore Gazy Inbal
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (250 p.)
Soggetto topico Biology, life sciences
Soggetto non controllato lymphoblast
pluripotent stem cells
FMR1
Gene editing
X chromosome
Fmr1
epigenetic gene silencing
FMR1 gene
Fragile X syndrome 1
repeat instability
characteristics that have the greatest impact
DNA instability
working memory
language development
mosaicism
CRISPR 3
clinical trials
autism spectrum disorders
Fmr1 KO mouse
automated vocal analysis
base excision repair (BER)
inhibitory control
cerebral spinal fluid
iPSC
drug development
targeted treatments
molecular biomarkers
viral vector
avoidance
biomarker
set-shifting
early identification
expansion
anxiety
planning
voice of the person
mismatch repair (MMR)
gene reactivation
double-strand break repair (DSBR)
newborn screening
intellectual disability
processing speed
voice of the patient
fragile X syndrome
adeno-associated virus
neurodevelopmental disorders
histone methylation
Non-homologous end-joining (NHEJ)
ASD
Fxr2
Fragile X-associated Tremor/Ataxia Syndrome 2
Trinucleotide Repeat 4
CGG Repeat Expansion Disease
DNA methylation
contraction
fragile X mental retardation protein
RNA:DNA hybrid
behavior
developmental disorders
cognition
females
FMRP
Fragile X Syndrome
unstable repeat diseases
protein synthesis
brain
cognitive flexibility
treatment development
fibroblast
PRC2
transcription coupled repair (TCR)
best practices
attention
Fragile X
executive function
ISBN 9783039215065
303921506X
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910367759103321
Gazy Inbal  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui